BLACKSBURG, Va.--(BUSINESS WIRE)--Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the appointment of Ronald B. Herberman, M.D., as its Chief Medical Officer - Oncology. Dr. Herberman will be responsible for overall leadership of Intrexon’s expanding anti-cancer clinical programs and related regulatory affairs.
